Lupin’s Mandideep Unit-2 Facility completes USFDA inspection with No Observations

14 Aug 2023 Evaluate

Lupin’s Unit-2 manufacturingfacility located in Mandideep, India, has successfully completed a GMP inspection by the United States Food and Drug Administration (USFDA). The inspection was conducted from August 7 to August 11, 2023 and concluded without any observations. 

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.


Lupin Share Price

2151.05 19.25 (0.90%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×